GlassScriptPhysician profile
Tracy Gose
NPI 1962014225
$4,519.33
in general payments reported to CMS, 2019-2025
21 companies · $831 in 2025
The $831 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $1,394 · 2023: $1,211 · 2024: $887 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,928.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $665.49 | 2022-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $626.23 | 2023-2025 | Infuse, Biotrue One Day, Miebo |
| Sun Pharmaceutical Industries INC. | $469.04 | 2021-2024 | Cequa |
| Allergan, INC. | $350.04 | 2021-2022 | |
| Sight Sciences, INC. | $336.38 | 2022-2023 | Omni Surgical System |
| Harrow Eye, LLC | $313.03 | 2023-2025 | Iheezo, Verkazia, Flarex |
| Glaukos Corporation | $276.58 | 2022-2023 | |
| Biotissue Holdings INC. | $268.57 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $237.61 | 2024-2025 | Xdemvy |
| Coopervision INC. | $214.32 | 2023-2024 | Myday Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $198.60 | 2022-2023 | Tecnis Iol |
| Oyster Point Pharma, INC. | $197.98 | 2022-2024 | Tyrvaya |
| Abbvie INC. | $97.55 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $74.52 | 2025 | Acthar |
| Genentech USA, INC. | $34.81 | 2025 | Vabysmo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $34.04 | 2021-2022 | |
| Amgen INC. | $28.32 | 2025 | Tepezza |
| Rayner Intraocular Lenses Limited | $27.81 | 2024 | Rayone Spheric, Rayner Cataract Set 1, Rayone Aspheric |
| Dompe US, INC. | $24.56 | 2025 | Oxervate |
| Thea Pharma INC. | $23.15 | 2023 | |
| Astellas Pharma US INC | $20.70 | 2024 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Gose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.